Literature DB >> 30045142

A Descriptive Analysis of the American Society for Dermatologic Surgery Presidents.

Kelly M MacArthur1, George J Hruza2.   

Abstract

BACKGROUND: The American Society of Dermatologic Surgery (ASDS) is the major educational organization for dermatologic surgery in the United States. Presidents are elected annually from among their members.
OBJECTIVE: The authors investigated the demographics, training, and achievements of the ASDS presidents.
MATERIALS AND METHODS: All ASDS presidents (1970-2017) were included. Data were gathered using publicly available information from websites, curriculum vitae, and PubMed. Living presidents were contacted by email (if available) to verify the collected data.
RESULTS: Of 46 ASDS presidents, 87% are male, with the first female president elected in 1994. Fifty-nine percent are members of the American College of Mohs Surgery. Seven presidents received dual fellowship training. Four presidents received a second graduate degree. Mean duration from residency to presidency was 22 years, with the mean age being 53 years. PubMed publication average was 34. All presidents have been affiliated with academic institutions, with 26% appointed as department chair and 30% serving as academic dermatologic surgery director.
CONCLUSION: The authors report that most of the ASDS presidents have been male with over half receiving Mohs surgery fellowship training. All have had academic affiliations at some point in their careers, with some named department chairs and/or elected as presidents of other national dermatologic societies.

Mesh:

Year:  2018        PMID: 30045142     DOI: 10.1097/DSS.0000000000001511

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  1 in total

1.  The Society of Black Academic Surgeons CV benchmarking initiative: Early career trends of academic surgical leaders.

Authors:  Byron D Hughes; Paris D Butler; Michael A Edwards; Carla M Pugh; Colin A Martin
Journal:  Am J Surg       Date:  2020-01-27       Impact factor: 2.565

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.